These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 32254730)

  • 1. Carboplatin prodrug conjugated Fe
    Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F
    J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
    Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

  • 5. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E; Mutlu P; Gündüz U
    Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
    Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
    Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A superparamagnetic Fe3O4-loaded polymeric nanocarrier for targeted delivery of evodiamine with enhanced antitumor efficacy.
    Lv Y; Ding G; Zhai J; Guo Y; Nie G; Xu L
    Colloids Surf B Biointerfaces; 2013 Oct; 110():411-8. PubMed ID: 23759382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
    Braga CB; Perli G; Becher TB; Ornelas C
    Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform.
    Liang Z; Li J; Zhu B
    Drug Des Devel Ther; 2020; 14():4519-4531. PubMed ID: 33149550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel synthesis of platinum complexes and their intracellular delivery to tumor cells by means of magnetic nanoparticles.
    Quarta A; Amorín M; Aldegunde MJ; Blasi L; Ragusa A; Nitti S; Pugliese G; Gigli G; Granja JR; Pellegrino T
    Nanoscale; 2019 Dec; 11(48):23482-23497. PubMed ID: 31808496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
    Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer.
    Wang Y; Luo Z; Zhou D; Wang X; Chen J; Gong S; Yu Z
    Biomater Sci; 2021 Jun; 9(11):4110-4119. PubMed ID: 33949442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity.
    Yang F; Li A; Liu H; Zhang H
    Drug Des Devel Ther; 2018; 12():3321-3333. PubMed ID: 30323564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity.
    Yao H; Chen S; Deng Z; Tse MK; Matsuda Y; Zhu G
    Inorg Chem; 2020 Aug; 59(16):11823-11833. PubMed ID: 32799491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
    Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
    Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine.
    Harringer S; Hejl M; Enyedy ÉA; Jakupec MA; Galanski MS; Keppler BK; Dyson PJ; Varbanov HP
    Dalton Trans; 2021 Jun; 50(23):8167-8178. PubMed ID: 34031671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High cancer selectivity and improving drug release from mesoporous silica nanoparticles in the presence of human serum albumin in cisplatin, carboplatin, oxaliplatin, and oxalipalladium treatment.
    Eslami Moghadam M; Sadeghi M; Mansouri-Torshizi H; Saidifar M
    Eur J Pharm Sci; 2023 Aug; 187():106477. PubMed ID: 37225004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin loaded magnetic Fe3O4/carboxymethylchitosan nanoparticles as tumor-targeted drug delivery system: Synthesis and in vitro characterization.
    Li G; Cao L; Zhou Z; Chen Z; Huang Y; Zhao Y
    Colloids Surf B Biointerfaces; 2015 Apr; 128():379-388. PubMed ID: 25779605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polyprodrug-based nanoplatform for cisplatin prodrug delivery and combination cancer therapy.
    Lin C; Tao Y; Saw PE; Cao M; Huang H; Xu X
    Chem Commun (Camb); 2019 Nov; 55(93):13987-13990. PubMed ID: 31687673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.